SCHEMBL21215581

SCHEMBL21215581

c1ccc(-c2ccc3cc(-c4cc(-c5ccc6nc(-c7ccccn7)ccc6c5)cc(-c5ccc6cc7ccccc7cc6n5)c4)ccc3n2)nc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 8/20 0.45
▸ RAB9A P51151 7/20 0.45
▸ POLB P06746 2/20 0.45
▸ KDM4E B2RXH2 8/20 0.43
▸ SMN1; SMN2 Q16637 6/20 0.43
▸ LMNA P02545 5/20 0.43
▸ PKM P14618 4/20 0.43
▸ TP53 P04637 4/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ MAPT P10636 3/20 0.43
▸ HSD17B10 Q99714 3/20 0.43
▸ TSHR P16473 1/20 0.43
▸ KLF5 Q13887 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ DYRK1A Q13627 1/20 0.41
▸ CCR1 P32246 2/20 0.41
▸ CCR5 P51681 2/20 0.41
▸ CCR8 P51685 2/20 0.41
▸ ALOX15 P16050 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21215774 0.93 NPC1 (0.44) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL21215771 0.91 NPC1 (0.44) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL21215633 0.90 KDM4E (0.50) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL18943871 0.89 NPC1 (0.50) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL21215775 0.88 KDM4E (0.42) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL24475651 0.88 SMN1; SMN2 (0.47) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL21215590 0.87 KDM4E (0.50) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL18943875 0.87 KDM4E (0.53) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL18943873 0.87 PIK3CD (0.50) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL24475740 0.86 PIK3CD (0.47) NPC1RAB9APOLBKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190233398-A1 HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2019-08-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190233398-A1 HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE USING SAME CRY1, CRY2, PER2 NPC1 4195/4885RAB9A 3313/4885POLB 702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback